Should wealthy nations be procuring booster doses?

Now that vaccines are enjoying widespread coverage among wealthy nations, and with the recent emergence of the Omicron variant and rapidly rising rates of infection in the United States and throughout Europe, many states have begun implementing domestic booster campaigns. But this presents thorny ethical problems involving vaccine distribution and global equity.